We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Alliant Energy
LNT
$18.3B
| $15M | 0.04% |
+274,243
| New | +$14.6M |
|
452
NetApp
NTAP
$35B
| $15M | 0.04% |
240,900
+77,900
| +48% | +$4.54M |
|
453
TotalEnergies
TTE
$195B
| $14.9M | 0.04% |
270,000
-80,000
| -23% | -$4.23M |
|
454
United Rentals
URI
$67.2B
| $14.9M | 0.04% |
89,515
-211,200
| -70% | -$30.7M |
|
|
PTLA
455
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.9M | 0.04% |
625,000
+25,000
| +4% | +$690K |
|
|
DRE
456
DELISTED
Duke Realty Corp.
DRE
| $14.8M | 0.04% |
428,200
+5,100
| +1% | +$176K |
|
|
VAR
457
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.8M | 0.04% |
104,395
+70,000
| +204% | +$8.93M |
|
458
Cencora
COR
$60.6B
| $14.8M | 0.04% |
173,900
-8,300
| -5% | -$711K |
|
459
Amalgamated Financial
AMAL
$1.48B
| $14.7M | 0.04% |
758,005
-40,900
| -5% | -$754K |
|
460
Norwegian Cruise Line
NCLH
$8.51B
| $14.7M | 0.04% |
252,400
-11,800
| -4% | -$623K |
|
461
Semtech
SMTC
$11B
| $14.7M | 0.04% |
278,567
+49,000
| +21% | +$2.45M |
|
|
UROV
462
DELISTED
Urovant Sciences Ltd.
UROV
| $14.7M | 0.04% |
950,000
-25,000
| -3% | -$271K |
|
463
Dentsply Sirona
XRAY
$2.68B
| $14.7M | 0.04% |
259,900
-212,300
| -45% | -$11.8M |
|
464
VanEck Gold Miners ETF
GDX
$22.6B
| $14.6M | 0.04% |
500,000
-1,100,000
| -69% | -$30.1M |
|
465
Hormel Foods
HRL
$13.8B
| $14.6M | 0.04% |
324,146
-1,400
| -0.4% | -$60.3K |
|
466
IDEX
IEX
$17B
| $14.6M | 0.04% |
84,626
+38,026
| +82% | +$6.15M |
|
467
Lamb Weston
LW
$7.22B
| $14.5M | 0.04% |
169,000
-8,100
| -5% | -$652K |
|
468
Incyte
INCY
$24.2B
| $14.5M | 0.04% |
166,052
+40,100
| +32% | +$3.43M |
|
469
Brown-Forman Class B
BF.B
$13.2B
| $14.3M | 0.04% |
211,132
-10,100
| -5% | -$656K |
|
|
NOVA
470
DELISTED
Sunnova Energy
NOVA
| $14.2M | 0.03% |
1,270,000
-130,000
| -9% | -$1.35M |
|
471
Old Dominion Freight Line
ODFL
$44.1B
| $14.1M | 0.03% |
+223,500
| New | +$13.7M |
|
472
Jacobs Solutions
J
$15.9B
| $14.1M | 0.03% |
189,959
+19,169
| +11% | +$1.45M |
|
473
American Airlines Group
AAL
$10.1B
| $14.1M | 0.03% |
489,882
-21,600
| -4% | -$616K |
|
474
Viavi Solutions
VIAV
$9.12B
| $14M | 0.03% |
934,000
+104,000
| +13% | +$1.56M |
|
|
KIN
475
DELISTED
Kindred Biosciences, Inc.
KIN
| $14M | 0.03% |
1,650,000
| – | – |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.